FGF21 and fatty liver disease: Characterization of the phenotypic changes in Ahnak KO mice, including reduced hepatic steatosis, decreased adiposity, and increased energy expenditure, establishes AHNAK as a novel regulator of FGF21 for the modulation of hepatic fatty acid metabolism.